Market overview
Orthopaedics and spine represent one of the most established, technically demanding, and commercially significant segments within the global medical device industry. The sector continues to demonstrate resilient growth, driven by ageing populations, increasing procedure volumes, technological innovation, and expanding access to surgical care worldwide.
In 2025, the global orthopaedic devices market is estimated at approximately $55–65 billion, with the spinal implants and surgical devices market contributing a further $14–15 billion. Combined, this places the orthopaedics & spine segment in the $70–80 billion+ range globally.
Against an estimated $570+ billion global medical devices market, orthopaedics and spine account for approximately 12–14% of total industry revenue, positioning it among the largest therapeutic device categories globally - alongside cardiovascular and in vitro diagnostics.
- Estimated global CAGR: ~5–7% (orthopaedics), ~4–6% (spine)
- Market profile: Large, competitive, and highly relationship-driven
- Key growth drivers: Degenerative disease, sports injuries, minimally invasive surgery, robotics, biologics, and procedural innovation
Leading Companies in Orthopaedics & Spine
Dedicated Orthopaedics & Spine Consultants
Anthony Jackson
Reuben Mundler-May
Reuben Mundler-May